Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Aurobindo Pharma Ltd.
NSE: AUROPHARMA
|
BSE: 524804
|
ISIN: INE406A01037
|
Industry: Pharmaceuticals
|
Mid-range Performer
1099.4000
-1.60
(
-0.15
%)
NSE
Oct 20, 2025
15:31 PM
26.68% Fall from 52W High
Volume:
967.5K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Aurobindo Pharma Ltd.
12 Nov 2024
1099.40
-0.15%
Result Update:Aurobindo Pharma
Buy:
Aurobindo Pharma Ltd.
by
Axis Direct
Target: 1460 | Upside : 32.8%
Target
Axis Direct
We maintain our BUY recommendation on Aurobindo Pharma with a target price of Rs 1,460/share.
Aurobindo Pharma Ltd. has an
average target
of 1403.50 from 10 brokers.
More from Aurobindo Pharma Ltd.
Recommended
Market closes higher, Reliance Industries' Q2FY26 net profit grows 10% YoY
Trendlyne Marketwatch |
20 Oct 2025, 03:57PM
Five Interesting Stocks Today - October 17, 2025
The Baseline |
17 Oct 2025
A deal is called off, increasing the chance for Aurobindo Pharma to be debt free
|
15 Jul 2020